Retraction

Proteasome Inhibition Blocks NF-KappaB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

Paper Information

Record ID:
9605
Author(s):
Ali R Jazirehi
James S Economou
Journal:
Molecular Cancer Therapeutics ( American Association for Cancer Research )
Publication Date:
April 24, 2012
Retraction Date:
May 01, 2017 (8.6 years years ago)
Subjects:
Broad Categories:
Medicine Biology
Institution:
Departments of Surgery, Microbiology, Immunology, and Molecular Genetics, and Molecular and Medical Pharmacology, and the Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, California
Country:
🇺🇸 United States
Article Type:
Research Article
Publisher:
American Association for Cancer Research
Open Access:
Yes
DOI:
10.1158/1535-7163.MCT-11-0814
PubMed ID:
22532603
Retraction PubMed ID:
28468866

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1158/1535-7163.MCT-17-0084

Citations (13)

13
Total Citations
2
Post-Retraction
(15.4%)
10
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
1613 Days since retraction (latest)
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Sep 2021
1613 days after retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Sep 2017
123 days after retraction
Paper citing Molecular Mechanism of MART-1+/A*0201+ Human Melan...
Unknown Authors
Unknown Journal
Published: May 2017
Same day as retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Dec 2015
504 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Sep 2015
608 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Jul 2015
651 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Feb 2015
796 days before retraction
Paper citing Molecular Mechanism of MART-1+/A*0201+ Human Melan...
Unknown Authors
Unknown Journal
Published: Nov 2014
912 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Nov 2014
912 days before retraction
Paper citing Molecular Mechanism of MART-1+/A*0201+ Human Melan...
Unknown Authors
Unknown Journal
Published: Mar 2014
1141 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Feb 2014
1185 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: Sep 2013
1327 days before retraction
Paper citing Proteasome Inhibition Blocks NF-KappaB and ERK1/2 ...
Unknown Authors
Unknown Journal
Published: May 2013
1441 days before retraction
Quick Stats
Total Citations: 13
Years Since Retraction: 8.6 years
Open Access: Yes
Last Checked: Never
Related Papers
Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma …
Molecular Cancer Therapeutics • 82 citations
Regulation of OSU-03012 Toxicity by ER Stress Proteins and …
Molecular Cancer Therapeutics • 41 citations
In Vitro and In Vivo Interactions between the HDAC6 Inhibit…
Molecular Cancer Therapeutics • 35 citations
Obatoclax Interacts Synergistically with the Irreversible P…
Molecular Cancer Therapeutics • 29 citations
Carfilzomib Interacts Synergistically with Histone Deacetyl…
Molecular Cancer Therapeutics • 57 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice